De Bortoli Alessandro, Ohm Ole-Jørgen, Hoff Per Ivar, Sun Li-Zhi, Schuster Peter, Solheim Eivind, Chen Jian
Department of Heart Disease, Haukeland University Hospital, 5021, Bergen, Norway.
J Interv Card Electrophysiol. 2013 Oct;38(1):19-26. doi: 10.1007/s10840-013-9816-4. Epub 2013 Jul 7.
The adjunctive ablation of areas of complex fractionated electrogram (CFE) to pulmonary vein isolation (PVI) is an emerging strategy for patients with non-paroxysmal atrial fibrillation (AF). We studied the long-term outcomes of this approach.
Sixty-six patients (mean age 58 ± 9, 86.4 % male) with non-paroxysmal AF underwent ablation procedures consisting of PVI plus extensive CFE ablation. Post-ablation atrial tachycardia (AT) was also targeted if presented. All patients were followed up regularly on an ambulatory basis by means of ECG and Holter recordings.
After a mean follow-up period of 40 ± 14 months and 1.7 ± 0.7 procedures, 38 patients (57.6 %) were free of arrhythmias, 15 (22.7 %) displayed clinical improvement and 13 (19.7 %) suffered recurrences of persistent AF/AT. Females displayed poorer long-term outcomes than males (arrhythmia-free 22.2 vs. 63.2 %, p < 0.05). Multivariate analysis demonstrated that long duration of uninterrupted AF prior to the procedure was an additional predictor of long-term failure (odds ratio 1.49, p < 0.01). ROC analysis (area under curve 0.80; p < 0.001) estimated 3.5 years as the optimal cut-off point for predicting long-term failure (sensitivity 85 %, specificity 74 %). The cumulative data showed a significantly higher percentage of arrhythmia-free patients when the duration of AF had been ≤ 2 years (69.7 %) and ≤ 4 years (68.9 %) than when it was > 4 years (33.3 %; p < 0.01).
PVI + CFE ablation in non-paroxysmal AF appears to provide a reasonable proportion of arrhythmia-free patients during long-term follow-up. Poorer long-term results can be expected among female patients and those with an uninterrupted AF duration of > 4 years.
对于非阵发性心房颤动(AF)患者,在肺静脉隔离(PVI)基础上辅助消融复杂碎裂电图(CFE)区域是一种新兴策略。我们研究了该方法的长期疗效。
66例非阵发性AF患者(平均年龄58±9岁,男性占86.4%)接受了包括PVI加广泛CFE消融的消融手术。若出现消融后房性心动过速(AT)也进行靶向治疗。所有患者通过心电图和动态心电图记录进行定期门诊随访。
平均随访40±14个月,进行了1.7±0.7次手术,38例患者(57.6%)无心律失常,15例(22.7%)临床症状改善,13例(19.7%)持续性AF/AT复发。女性患者的长期疗效比男性差(无心律失常分别为22.2%和63.2%,p<0.05)。多因素分析表明,手术前AF持续时间长是长期失败的另一个预测因素(比值比1.49,p<0.01)。ROC分析(曲线下面积为0.80;p<0.001)估计3.5年为预测长期失败的最佳切点(敏感性85%,特异性74%)。累积数据显示,AF持续时间≤2年(69.7%)和≤4年(68.9%)时无心律失常患者的比例显著高于AF持续时间>4年时(33.3%;p<0.01)。
非阵发性AF患者行PVI+CFE消融在长期随访中似乎能使相当比例的患者无心律失常。女性患者以及AF持续时间>4年的患者长期疗效可能较差。